Skip to main content
SpringerLink
Log in

Staging of Colorectal Cancer (Including Staging After Neoadjuvant Therapy)

  • Chapter
  • First Online:
Multidisciplinary Treatment of Colorectal Cancer

  • 2164 Accesses

Abstract

Pathological examination of colorectal cancer is the basis for further treatment. Staging of the tumor predicts prognosis and indicates the necessity of adjuvant therapy. Neoadjuvant treatment may hamper staging and is subject to ongoing research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sobin LH, Wittekind C. UICC TNM classification of malignant tumours. 5th ed. New York: Wiley; 1997.

    Google Scholar 

  2. Sobin LH, Greene FL. TNM classification. Cancer. 2001;92(2):452.

    Article  CAS  PubMed  Google Scholar 

  3. Sobin LH, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.

    Google Scholar 

  4. Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJH, Leer JWH, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19(7):1976–84.

    CAS  PubMed  Google Scholar 

  5. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol. 1997;43:133–7.

    Article  CAS  PubMed  Google Scholar 

  6. Radu C, Berglund K, Pahlman L, Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study. Radiother Oncol. 2008;87(3):343–9.

    Google Scholar 

  7. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17(8):2396–402.

    CAS  PubMed  Google Scholar 

  8. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93(10):1215–23.

    Article  CAS  PubMed  Google Scholar 

  9. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24(28):4620–5.

    Article  PubMed  Google Scholar 

  10. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114–23.

    Article  CAS  PubMed  Google Scholar 

  11. Rullier A, Laurent C, Vendrely V, Le BB, Bioulac-Sage P, Rullier E. Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol. 2005;29(5):602–6.

    Article  PubMed  Google Scholar 

  12. Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol. 2004;28(2):215–23.

    Article  PubMed  Google Scholar 

  13. Smith KD, Tan D, Das P, Chang GJ, Kattapogu K, Feig BW, et al. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologica complete response to preoperative chemoradiation. Ann Surg. 2010;251(2):261–4.

    Article  PubMed  Google Scholar 

  14. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a “wait and see” policy justified? Dis Colon Rectum. 2008;51(1):10–20.

    Article  CAS  PubMed  Google Scholar 

  15. Prall F, Wohlke M, Klautke G, Schiffmann L, Fietkau R, Barten M. Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum. APMIS. 2006;114(3):201–10.

    Article  PubMed  Google Scholar 

  16. Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR, et al. Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis. 2005;20(5):434–9.

    Article  PubMed  Google Scholar 

  17. Morgan MJ, Koorey DJ, Painter D, Findlay M, Tran K, Stevens G, et al. Histological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer. Colorectal Dis. 2002;4(3):177–83.

    Article  PubMed  Google Scholar 

  18. Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008;71(2):456–61.

    Google Scholar 

  19. Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys. 2002;53(3):664–74.

    Article  PubMed  Google Scholar 

  20. Wijesuriya RE, Deen KI, Hewavisenthi J, Balawardana J, Perera M. Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Surg Today. 2005;35(6):442–5.

    Article  CAS  PubMed  Google Scholar 

  21. Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 2005;61(2):426–31.

    Article  PubMed  Google Scholar 

  22. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Kepca L, Winkler-Spytkowska B, Suwinski R, et al. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol. 2005;76(3):234–40.

    Article  PubMed  Google Scholar 

  23. Suarez J, Vera R, Balen E, Gomez M, Arias F, Lera JM et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis. 2008;10(6):563–8.

    Google Scholar 

  24. Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del RC, et al. Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis. 2005;7(5):472–9.

    Article  CAS  PubMed  Google Scholar 

  25. Stipa F, Zernecke A, Moore HG, Minsky BD, Wong WD, Weiser M, et al. Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol. 2004;11(2):187–91.

    Article  PubMed  Google Scholar 

  26. Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, et al. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 2005;12(2):111–6.

    Article  PubMed  Google Scholar 

  27. Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol. 2007;14(10):2766–72.

    Article  PubMed  Google Scholar 

  28. Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ, Sohn DK, et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer. 2006;106(8):1694–700.

    Article  PubMed  Google Scholar 

  29. Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum. 2008;51(3):277–83.

    Article  PubMed  Google Scholar 

  30. Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis. 2006;21(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  31. Shivnani AT, Small Jr W, Stryker SJ, Kiel KD, Lim S, Halverson AL, et al. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007;193(3):389–93.

    Article  PubMed  Google Scholar 

  32. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51(2):141–9.

    Article  CAS  PubMed  Google Scholar 

  33. Vironen J, Juhola M, Kairaluoma M, Jantunen I, Kellokumpu I. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. Int J Colorectal Dis. 2005;20(5):440–5.

    Article  CAS  PubMed  Google Scholar 

  34. Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23(34):8688–96.

    Article  PubMed  Google Scholar 

  35. Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol. 1989;42(2):162–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Radboud University Nijmegen Medical Center, Geert Grooteplein 2, Nijmegen, 6500 HB, The Netherlands

    Iris D. Nagtegaal MD, PhD

Authors
  1. Iris D. Nagtegaal MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iris D. Nagtegaal MD, PhD .

Editor information

Editors and Affiliations

  1. Institute of Regional Health Science, University of Southern Denmark, Odense, Denmark

    Gunnar Baatrup

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Nagtegaal, I.D. (2015). Staging of Colorectal Cancer (Including Staging After Neoadjuvant Therapy). In: Baatrup, G. (eds) Multidisciplinary Treatment of Colorectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-06142-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06142-9_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06141-2

  • Online ISBN: 978-3-319-06142-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation